Merck to buy idenix for $3.85b for its HCV pipelines.
http://finance.yahoo.com/q?s=IDIX
Idenix share price was only slightly more than $3 around Nov 2013, now it is $23.79.
What happened to Biota's HCV program? With the previous managements' track record, I do not expect them to safeguard BOTA's valuable assets.
Personally, very happy to see Melbourne lab is to be shut down.
Add to My Watchlist
What is My Watchlist?